Some randomized controlled trials have reported that, as a classical anti-diabetic medicine, the symptoms of HF patients may be alleviated by taking sodium-glucose co-transporter 2 (SGLT2) inhibitor [4,5]. Here, SLC5A2 is linked to hydrops fetalis.